. Author manuscript; available in PMC: 2019 Jul 10.

Published in final edited form as: Am Soc Clin Oncol Educ Book. 2017;37:575–585. doi: 10.14694/EDBK_175171

TABLE 2.

Large Registry Studies of Outcomes of ASCT for Older Patients With Myeloma

Study	Year	Age (Years)	No. of Patients	Conditioning	NRM	OS at 2 Years
Auner et al⁷⁷	1991–1996	60–64	383	Melphalan	3.9	62.5
		65–69	75		8.0	55.3
		> 70	2		NA	NA
	1996–2000	60–64	1,835		3.6	77.6
		65–70	718		4.1	71.9
		> 70	100		4.0	70.8
	2001–2005	60–64	4,253		2.4	81.1
		65–69	2,478		2.7	79.3
		> 70	497		2.4	72.7
	2006–2010	60–64	6,518		1.8	86.3
		65–69	3,860		2.1	82.9
		> 70	740		2.0	80.2
Sharma et al⁷⁸	2008–2011	60–64	2,617	Melphalan	2.0	85
		65–69	2,049			83
		> 70	946

Abbreviations: ASCT, autologous stem cell transplantation; NRM, non-relapse mortality; NA, not available; OS, overall survival.